ArticleClinical research in cardiology : official journal of the German Cardiac Society2026
Comparison of iron deficiency markers in patients with advanced heart failure.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionIron deficiency (ID) is a common comorbidity in patients with heart failure (HF). It is associated with reduced performance, frequent hospitalizations and low quality of life. There is an ongoing debate about the correct definition of ID in HF. PURPOSE: Refinement of the ID determination in patients with advanced HF. Evaluation of the association of iron metabolism parameters with other clinical characteristics. PATIENTS AND
methodsOne hundred-two patients with advanced HF were included, 48 in-patients, out-patients without LVAD and 25 of patients with LVAD implanted. In addition to conventional tests, we monitored iron metabolism parameters. The prevalence of ID was compared according to both the original and the updated ID definition. Correlations between individual iron markers and patients' functional capacity were measured.
resultsThe prevalence of ID in patients with advanced HF was 65%. There was no statistically significant difference in individual iron parameters between the groups. All parameters except ferritin correlated with NT-proBNP in the in-patient group. Serum iron correlated most strongly with NT-proBNP and CRP across all groups. The sTfR parameter correlated the most with right heart catheterization parameters, serum iron and TSAT were the most specific parameters related to functional status.
conclusionPatients with more advanced HF and severe limitation of functional capacity had worse iron parameters. Ferritin seems to be the less specific marker of ID, while detecting ID using serum iron and TSAT seems to be reliable. The correlation of ferritin with functional status or haemodynamics was the weakest of all the parameters studied.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.